Antiretroviral therapy coverage in Afghanistan
Afghanistan: Antiretroviral therapy coverage was 11.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Afghanistan, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Afghanistan is 11.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 10.0% on the previous year and up 120.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Afghanistan peaked at 11.0% in 2017 and was at its lowest, 0.0%, in 2000.
Afghanistan ranks 143rd of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Afghanistan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 1.0% | — |
| 2010 | 1.0% | +0.0% |
| 2011 | 3.0% | +200.0% |
| 2012 | 3.0% | +0.0% |
| 2013 | 4.0% | +33.3% |
| 2014 | 5.0% | +25.0% |
| 2015 | 5.0% | +0.0% |
| 2016 | 8.0% | +60.0% |
| 2017 | 11.0% | +37.5% |
| 2018 | 11.0% | +0.0% |
| 2019 | 11.0% | +0.0% |
| 2020 | 11.0% | +0.0% |
| 2021 | 11.0% | +0.0% |
| 2022 | 10.0% | -9.1% |
| 2023 | 10.0% | +0.0% |
| 2024 | 11.0% | +10.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.1% | 0.0% | 1.0% | 10 |
| 2010s | 6.2% | 1.0% | 11.0% | 10 |
| 2020s | 10.6% | 10.0% | 11.0% | 5 |
Countries ranked near Afghanistan
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 812.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,735 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 19 (2025)
- Population ages 00-04, female, annual growth rate 1.78 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0002 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.75 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0002 units per US$ of GDP (2024)
Frequently asked questions
- What is antiretroviral therapy coverage in Afghanistan?
- Antiretroviral therapy coverage in Afghanistan was 11.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Afghanistan?
- The highest recorded value was 11.0% in 2017.
- What is the lowest antiretroviral therapy coverage recorded in Afghanistan?
- The lowest recorded value was 0.0% in 2000.
- How does Afghanistan rank for antiretroviral therapy coverage?
- Afghanistan ranks 143rd out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Afghanistan?
- Over the last ten years it is up 120.0%. The long-run trend across the full record is volatile.
- Where does this Afghanistan data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.